By contrast, the day 6 cells displayed an upregulation of pathways related to ribosome, Rap1 signaling, and cardiomyopathy in response to LPS/nig treatment, which included genes such as VEGFA (Figure 4G,H). This evidence concerns the gene VEGFA and cardiomyopathy.